Modifications to five-substituted 3,3-diethyl-4,5-dihydro-2(3H)-furanones en route to novel muscarinic receptor ligands

被引:4
作者
Bhandare, Richie R. [1 ]
Canney, Daniel J. [1 ]
机构
[1] Temple Univ, Dept Pharmaceut Sci, Sch Pharm, Philadelphia, PA 19140 USA
关键词
Muscarinic receptors; Lactone; Diphenylmethylpiperazine; ACETYLCHOLINE-RECEPTOR; BINDING-SITE; M1; RECEPTOR; DERIVATIVES; ANTAGONISTS; DOCKING; AGONISTS; SUBTYPE; MODEL;
D O I
10.1007/s00044-010-9349-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lead lactone-based ligands with modest affinity for muscarinic receptors were modified based on structure-activity relationship data in the literature to provide a new series of 5-substituted 4,5-dihydro-2(3H)-furanones. The modifications included the addition of various nitrogen-containing heterocycles attached to substituted and unsubstituted aromatic rings. The target compounds were synthesized in modest yields and evaluated in preliminary muscarinic binding assays. A lactone-based ligand containing a diphenylmethylpiperazine moiety was identified as a nonselective muscarinic ligand with IC(50) of 340 nM. The design of future ligands will be based, in part, on structure-activity data reported herein.
引用
收藏
页码:558 / 565
页数:8
相关论文
共 24 条
[1]   Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder [J].
Abrams, Paul ;
Andersson, Karl-Erik ;
Buccafusco, Jerry J. ;
Chapple, Christopher ;
de Groat, William Chet ;
Fryer, Alison D. ;
Kay, Gary ;
Laties, Alan ;
Nathanson, Neil M. ;
Pasricha, Pankaj Jay ;
Wein, Alan J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) :565-578
[2]  
Ahungena A, 1996, MED CHEM RES, V6, P618
[3]  
Ahungena A, 2003, MED CHEM RES, V12, P481
[4]   STRUCTURE AND ACTIVITY OF ACETYLCHOLINE [J].
BEERS, WH ;
REICH, E .
NATURE, 1970, 228 (5275) :917-&
[5]   Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor [J].
Burstein, ES ;
Spalding, TA ;
Brann, MR .
BIOCHEMISTRY, 1998, 37 (12) :4052-4058
[6]   Therapeutic opportunities for muscarinic receptors in the central nervous system [J].
Felder, CC ;
Bymaster, FP ;
Ward, J ;
DeLapp, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4333-4353
[7]   A model of the human M2 muscarinic acetylcholine receptor [J].
Jöhren, K ;
Höltje, HD .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (11) :795-801
[8]   SYNTHESIS AND ANTIMUSCARINIC PROPERTIES OF SOME N-SUBSTITUTED 5-(AMINOMETHYL)-3,3-DIPHENYL-2(3H)-FURANONES [J].
KAISER, C ;
SPAGNUOLO, CJ ;
ADAMS, TC ;
AUDIA, VH ;
DUPONT, AC ;
HATOUM, H ;
LOWE, VC ;
PROSSER, JC ;
STURM, BL ;
NORONHABLOB, L .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4415-4424
[9]   On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease [J].
Koch, HJ ;
Haas, S ;
Jürgens, T .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (24) :2915-2921
[10]   Substituted 2-(R)-methyl piperazines as muscarinic M2 selective ligands [J].
Kozlowski, JA ;
Zhou, GW ;
Tagat, JR ;
Lin, SI ;
McCombie, SW ;
Ruperto, VB ;
Duffy, RA ;
McQuade, RA ;
Crosby, G ;
Taylor, LA ;
Billard, W ;
Binch, H ;
Lachowicz, JE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) :791-794